| MIRALTA NARVAL EUROPA, FI F | RVI EUROPA | 33,78% | 38,57% | 97,88% | · |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | BIOTECNOLOGÍA | 36,19% | 23,86% | 97,85% | 260,62% |
| AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB AU DIS | RVI USA | 36,32% | 32,49% | 97,84% | · |
| AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB IE DIS | RVI USA | 36,26% | 33,35% | 97,83% | 227,98% |
| DWS INVEST CROCI SECTORS PLUS FC | RVI GLOBAL | 6,90% | 24,27% | 97,76% | · |
| AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB AE DIS | RVI USA | 36,24% | 33,17% | 97,74% | 227,27% |
| AMUNDI MSCI WORLD EX EUROPE UCITS ETF EUR CAP | RVI GLOBAL | 35,83% | 34,55% | 97,74% | · |
| FSSA INDIAN SUBCONTINENT ALL-CAP B GBP CAP | RVI ASIA EX-JAPÓN | 30,50% | 46,62% | 97,71% | · |
| WELLINGTON US RESEARCH EQUITY N EUR ACC | RVI USA | 35,77% | 28,43% | 97,69% | · |
| WELLINGTON US RESEARCH EQUITY N USD ACC | RVI USA | 35,84% | 27,72% | 97,68% | · |
